S&P 500   5,072.85 (+0.22%)
DOW   37,937.90 (+0.54%)
QQQ   432.57 (+0.35%)
AAPL   169.87 (-1.63%)
MSFT   416.80 (+0.76%)
META   502.29 (+0.41%)
GOOGL   155.22 (+0.23%)
AMZN   184.12 (+0.27%)
TSLA   156.52 (-3.07%)
NVDA   880.22 (+2.35%)
AMD   164.03 (+2.31%)
NIO   3.86 (-0.77%)
BABA   69.99 (-0.89%)
T   16.04 (-1.23%)
F   12.19 (-0.33%)
MU   122.19 (+0.68%)
GE   156.73 (+1.97%)
CGC   6.76 (-3.15%)
DIS   114.06 (+0.98%)
AMC   2.78 (+12.55%)
PFE   25.80 (-0.42%)
PYPL   63.76 (+0.39%)
XOM   119.18 (-0.42%)
S&P 500   5,072.85 (+0.22%)
DOW   37,937.90 (+0.54%)
QQQ   432.57 (+0.35%)
AAPL   169.87 (-1.63%)
MSFT   416.80 (+0.76%)
META   502.29 (+0.41%)
GOOGL   155.22 (+0.23%)
AMZN   184.12 (+0.27%)
TSLA   156.52 (-3.07%)
NVDA   880.22 (+2.35%)
AMD   164.03 (+2.31%)
NIO   3.86 (-0.77%)
BABA   69.99 (-0.89%)
T   16.04 (-1.23%)
F   12.19 (-0.33%)
MU   122.19 (+0.68%)
GE   156.73 (+1.97%)
CGC   6.76 (-3.15%)
DIS   114.06 (+0.98%)
AMC   2.78 (+12.55%)
PFE   25.80 (-0.42%)
PYPL   63.76 (+0.39%)
XOM   119.18 (-0.42%)
S&P 500   5,072.85 (+0.22%)
DOW   37,937.90 (+0.54%)
QQQ   432.57 (+0.35%)
AAPL   169.87 (-1.63%)
MSFT   416.80 (+0.76%)
META   502.29 (+0.41%)
GOOGL   155.22 (+0.23%)
AMZN   184.12 (+0.27%)
TSLA   156.52 (-3.07%)
NVDA   880.22 (+2.35%)
AMD   164.03 (+2.31%)
NIO   3.86 (-0.77%)
BABA   69.99 (-0.89%)
T   16.04 (-1.23%)
F   12.19 (-0.33%)
MU   122.19 (+0.68%)
GE   156.73 (+1.97%)
CGC   6.76 (-3.15%)
DIS   114.06 (+0.98%)
AMC   2.78 (+12.55%)
PFE   25.80 (-0.42%)
PYPL   63.76 (+0.39%)
XOM   119.18 (-0.42%)
S&P 500   5,072.85 (+0.22%)
DOW   37,937.90 (+0.54%)
QQQ   432.57 (+0.35%)
AAPL   169.87 (-1.63%)
MSFT   416.80 (+0.76%)
META   502.29 (+0.41%)
GOOGL   155.22 (+0.23%)
AMZN   184.12 (+0.27%)
TSLA   156.52 (-3.07%)
NVDA   880.22 (+2.35%)
AMD   164.03 (+2.31%)
NIO   3.86 (-0.77%)
BABA   69.99 (-0.89%)
T   16.04 (-1.23%)
F   12.19 (-0.33%)
MU   122.19 (+0.68%)
GE   156.73 (+1.97%)
CGC   6.76 (-3.15%)
DIS   114.06 (+0.98%)
AMC   2.78 (+12.55%)
PFE   25.80 (-0.42%)
PYPL   63.76 (+0.39%)
XOM   119.18 (-0.42%)
LON:COS

Collagen Solutions plc (COS.L) (COS) Share Price, News & Analysis

Today's Range
N/A
50-Day Range
6.63
6.63
52-Week Range
N/A
Volume
15,000 shs
Average Volume
298,181 shs
Market Capitalization
£30.99 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
COS stock logo

About Collagen Solutions plc (COS.L) Stock (LON:COS)

Collagen Solutions plc sources, develops, manufactures, and supplies medical grade collagen components and biomaterials for use in research, regenerative medicines, medical devices, and in-vitro diagnostics in Europe, the Middle East, Africa, North America, and Asia. It offers collagen soluble collagen, collagen powders, fibrillars, collagen gels, freeze dried collagen, and other products for use in orthopaedic, sports medicine, dental, wound care, cardiovascular, general, plastic, and reconstructive surgeries, as well as 3D cell culture research; Bovine Pericardium is used in bio-prosthetic heart valves, dural closures, bone and dental membranes, and surgical buttressing applications; and BSE-free bovine biomaterials. The company also provides product development and contract manufacturing services, including technology transfer and regulatory support services for collagen-based products. It serves pharmaceutical and medical device companies. Collagen Solutions plc was incorporated in 2013 and is based in London, the United Kingdom.

COS Stock News Headlines

WAG Payment Solutions PLC (WPS)
Collagen Solutions Plc (COSA)
Can't believe it's happening again
One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.
Alpha Financial Markets Consulting plc (AFM.L)
Best Collagen Supplements Of 2023
Courteville Business Solutions PLC
Can't believe it's happening again
One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.
HYVE.L - Hyve Group Plc
China is Ravaging Africa's Donkey Population
See More Headlines
Receive COS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Collagen Solutions plc (COS.L) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
7/31/2020
Today
4/16/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
48
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£4.01 million
Cash Flow
GBX 0.50 per share
Book Value
GBX 4 per share

Miscellaneous

Free Float
N/A
Market Cap
£30.99 million
Optionable
Not Optionable
Beta
N/A
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Mr. Jamal D. Rushdy (Age 48)
    CEO & Director
    Comp: $243.5k
  • Ms. Hilary G. Spence
    CFO, Company Sec. & Director
  • Mr. Tom Hyland (Age 55)
    Chief Technical Adviser
    Comp: $72.1k
  • Dr. John Higgins
    Chief Technology Officer
  • Ms. Lisa Baderoon
    Head of Investor Relations
  • Mr. Brad Selman
    VP of Global Sales & Marketing
  • Ms. Diane Mitchell MBA
    Chief Commercial Officer
  • Mr. Kevin Darling
    VP of Tissue Products & MD of New Zealand
  • Ms. Gillian Nancy Black (Age 57)
    Company Sec.
  • Dr. Stewart White Ph.D. (Age 49)
    MBA, Consultant & Member of Scientific Advisory Board

COS Stock Analysis - Frequently Asked Questions

How were Collagen Solutions plc (COS.L)'s earnings last quarter?

Collagen Solutions plc (COS.L) (LON:COS) issued its quarterly earnings results on Friday, July, 31st. The company reported ($0.76) earnings per share for the quarter.

What other stocks do shareholders of Collagen Solutions plc (COS.L) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Collagen Solutions plc (COS.L) investors own include ReNeuron Group (RENE), Sareum (SAR), Oxford Biomedica (OXB), ValiRx (VAL), Active Energy Group (AEG), Norcros (NXR), Oxford Instruments (OXIG), Proteome Sciences (PRM), Perseus Mining (PRU) and Nektar Therapeutics (NKTR).

How do I buy shares of Collagen Solutions plc (COS.L)?

Shares of COS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:COS) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners